Ceftobiprole medocaril is noninferior to combination therapy with ceftazidime and linezolid for nosocomial pneumonia

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1610, 2007-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia

By Lagacé-Wiens Philippe RS  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 789-799

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Continuous and Intermittent Ceftazidime during the Treatment of Nosocomial Pneumonia

By Nicolau D.P.  

Clinical Drug Investigation, Vol. 18, Iss. 2, 1999-08 ,pp. : 133-139

Adis International

Access to resources Recommend Favorite

STRAUSS composes key note for ceftobiprole medocaril in cSSSIs

By  

Inpharma, Vol. 1, Iss. 1563, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Ceftobiprole Medocaril: BAL5788, JNJ 30982081, JNJ30982081, RO 65-5788, RO 655788

By Adis International Limited  

Drugs in R&D, Vol. 7, Iss. 5, 2006-01 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite

Cefepime versus Ceftazidime for Treatment of Pneumonia

By Konstantinou K   Baddam K   Lanka A   Reddy K   Zervos M  

The Journal of International Medical Research, Vol. 32, Iss. 1, 2004-01 ,pp. : 84-93

Field House Publishing

Access to resources Recommend Favorite